Exact Mass: 451.1671504
Exact Mass Matches: 451.1671504
Found 140 metabolites which its exact mass value is equals to given mass value 451.1671504
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Flucythrinate
4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide
C22H27ClFN3O4 (451.16740240000007)
Succinyl-trialanine-4-nitroanilide
(1S,4R)-1-(beta-D-Glucopyranosyloxy)-4-(6-deoxy-beta-D-gulopyranosyloxy)-2-cyclopentene-1-carboxamide
C18H29NO12 (451.16896740000004)
Ala Cys Cys Arg
Ala Cys Arg Cys
Ala Arg Cys Cys
Cys Ala Cys Arg
Cys Ala Arg Cys
Cys Cys Ala Arg
Cys Cys Arg Ala
Cys Asp Lys Ser
C16H29N5O8S (451.17367540000004)
Cys Asp Ser Lys
C16H29N5O8S (451.17367540000004)
Cys Lys Asp Ser
C16H29N5O8S (451.17367540000004)
Cys Lys Ser Asp
C16H29N5O8S (451.17367540000004)
Cys Gln Thr Thr
C16H29N5O8S (451.17367540000004)
Cys Arg Ala Cys
Cys Arg Cys Ala
Cys Ser Asp Lys
C16H29N5O8S (451.17367540000004)
Cys Ser Lys Asp
C16H29N5O8S (451.17367540000004)
Cys Thr Gln Thr
C16H29N5O8S (451.17367540000004)
Cys Thr Thr Gln
C16H29N5O8S (451.17367540000004)
Asp Cys Lys Ser
C16H29N5O8S (451.17367540000004)
Asp Cys Ser Lys
C16H29N5O8S (451.17367540000004)
Asp Phe Gly Asn
Asp Phe Asn Gly
Asp Gly Phe Asn
Asp Gly Asn Phe
Asp Lys Cys Ser
C16H29N5O8S (451.17367540000004)
Asp Lys Ser Cys
C16H29N5O8S (451.17367540000004)
Asp Asn Phe Gly
Asp Asn Gly Phe
Asp Ser Cys Lys
C16H29N5O8S (451.17367540000004)
Asp Ser Lys Cys
C16H29N5O8S (451.17367540000004)
Phe Asp Gly Asn
Phe Asp Asn Gly
Phe Gly Asp Asn
Phe Gly Asn Asp
Phe Asn Asp Gly
Phe Asn Gly Asp
Gly Asp Phe Asn
Gly Asp Asn Phe
Gly Phe Asp Asn
Gly Phe Asn Asp
Gly Asn Asp Phe
Gly Asn Phe Asp
Lys Cys Asp Ser
C16H29N5O8S (451.17367540000004)
Lys Cys Ser Asp
C16H29N5O8S (451.17367540000004)
Lys Asp Cys Ser
C16H29N5O8S (451.17367540000004)
Lys Asp Ser Cys
C16H29N5O8S (451.17367540000004)
Lys Ser Cys Asp
C16H29N5O8S (451.17367540000004)
Lys Ser Asp Cys
C16H29N5O8S (451.17367540000004)
Met Asn Ser Thr
C16H29N5O8S (451.17367540000004)
Met Asn Thr Ser
C16H29N5O8S (451.17367540000004)
Met Gln Ser Ser
C16H29N5O8S (451.17367540000004)
Met Ser Asn Thr
C16H29N5O8S (451.17367540000004)
Met Ser Gln Ser
C16H29N5O8S (451.17367540000004)
Met Ser Ser Gln
C16H29N5O8S (451.17367540000004)
Met Ser Thr Asn
C16H29N5O8S (451.17367540000004)
Met Thr Asn Ser
C16H29N5O8S (451.17367540000004)
Met Thr Ser Asn
C16H29N5O8S (451.17367540000004)
Asn Asp Phe Gly
Asn Asp Gly Phe
Asn Phe Asp Gly
Asn Phe Gly Asp
Asn Gly Asp Phe
Asn Gly Phe Asp
Asn Met Ser Thr
C16H29N5O8S (451.17367540000004)
Asn Met Thr Ser
C16H29N5O8S (451.17367540000004)
Asn Ser Met Thr
C16H29N5O8S (451.17367540000004)
Asn Ser Thr Met
C16H29N5O8S (451.17367540000004)
Asn Thr Met Ser
C16H29N5O8S (451.17367540000004)
Asn Thr Ser Met
C16H29N5O8S (451.17367540000004)
Gln Cys Thr Thr
C16H29N5O8S (451.17367540000004)
Gln Met Ser Ser
C16H29N5O8S (451.17367540000004)
Gln Ser Met Ser
C16H29N5O8S (451.17367540000004)
Gln Ser Ser Met
C16H29N5O8S (451.17367540000004)
Gln Thr Cys Thr
C16H29N5O8S (451.17367540000004)
Gln Thr Thr Cys
C16H29N5O8S (451.17367540000004)
Arg Ala Cys Cys
Arg Cys Ala Cys
Arg Cys Cys Ala
Ser Cys Asp Lys
C16H29N5O8S (451.17367540000004)
Ser Cys Lys Asp
C16H29N5O8S (451.17367540000004)
Ser Asp Cys Lys
C16H29N5O8S (451.17367540000004)
Ser Asp Lys Cys
C16H29N5O8S (451.17367540000004)
Ser Lys Cys Asp
C16H29N5O8S (451.17367540000004)
Ser Lys Asp Cys
C16H29N5O8S (451.17367540000004)
Ser Met Asn Thr
C16H29N5O8S (451.17367540000004)
Ser Met Gln Ser
C16H29N5O8S (451.17367540000004)
Ser Met Ser Gln
C16H29N5O8S (451.17367540000004)
Ser Met Thr Asn
C16H29N5O8S (451.17367540000004)
Ser Asn Met Thr
C16H29N5O8S (451.17367540000004)
Ser Asn Thr Met
C16H29N5O8S (451.17367540000004)
Ser Gln Met Ser
C16H29N5O8S (451.17367540000004)
Ser Gln Ser Met
C16H29N5O8S (451.17367540000004)
Ser Ser Met Gln
C16H29N5O8S (451.17367540000004)
Ser Ser Gln Met
C16H29N5O8S (451.17367540000004)
Ser Thr Met Asn
C16H29N5O8S (451.17367540000004)
Ser Thr Asn Met
C16H29N5O8S (451.17367540000004)
Thr Cys Gln Thr
C16H29N5O8S (451.17367540000004)
Thr Cys Thr Gln
C16H29N5O8S (451.17367540000004)
Thr Met Asn Ser
C16H29N5O8S (451.17367540000004)
Thr Met Ser Asn
C16H29N5O8S (451.17367540000004)
Thr Asn Met Ser
C16H29N5O8S (451.17367540000004)
Thr Asn Ser Met
C16H29N5O8S (451.17367540000004)
Thr Gln Cys Thr
C16H29N5O8S (451.17367540000004)
Thr Gln Thr Cys
C16H29N5O8S (451.17367540000004)
Thr Ser Met Asn
C16H29N5O8S (451.17367540000004)
Thr Ser Asn Met
C16H29N5O8S (451.17367540000004)
Thr Thr Cys Gln
C16H29N5O8S (451.17367540000004)
Thr Thr Gln Cys
C16H29N5O8S (451.17367540000004)
cyano(3-phenoxyphenyl)methyl (2S)-2-[4-(difluoromethoxy)phenyl]-3-methylbutanoate
N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide
C21H29N3O4S2 (451.15993940000004)
2-{4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-D]pyrimidin-5-YL)-ethyl]-benzoylamino}-4-(2H-tetrazol-5-YL)-butyric acid
C20H21N9O4 (451.17164260000004)
4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide
C22H27ClFN3O4 (451.16740240000007)
3-fluoro-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
C21H26FN3O5S (451.1577118000001)
2-[(2R,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2S,5S,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2S,5R,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
N-[(2S,3R,6S)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2S,5R,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2R,5R,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2S,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2R,5R,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
2-[(2R,5S,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
C21H26FN3O5S (451.1577118000001)
N-[(2R,3S,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
C21H26FN3O5S (451.1577118000001)
N-[(2S,3R,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
C21H26FN3O5S (451.1577118000001)
Flucythrinate
PRGL493
PRGL493 is a potent and selective long-chain acyl-CoA synthetase 4 (ACSL4) inhibitor. PRGL493 blocks cell proliferation and tumor growth in both breast and prostate cellular and animal models. PRGL493 is used for cancer research[1].